mln0128
Showing 1 - 9 of 9
Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)
Completed
- Metastatic Breast Cancer
- Solid Tumors
- Alisertib
- MLN0128
-
Aurora, ColoradoUniversity of Colorado Cancer Center
May 17, 2022
Anaplastic Thyroid Cancer, Thyroid Cancer Trial in Newport Beach, Boston, Ann Arbor (MLN0128)
Active, not recruiting
- Anaplastic Thyroid Cancer
- Thyroid Cancer
- MLN0128
-
Newport Beach, California
- +2 more
Feb 18, 2022
Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)
Completed
- Clear-cell Metastatic Renal Cell Carcinoma
- Everolimus
- +2 more
-
Los Angeles, California
- +35 more
Nov 18, 2021
Merkel Cell Carcinoma Trial in Boston (MLN0128)
Completed
- Merkel Cell Carcinoma
- MLN0128
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 3, 2020
Metastatic Castration-Resistant Prostate Cancer Trial in New York (MLN0128)
Completed
- Metastatic Castration-Resistant Prostate Cancer
- MLN0128
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 13, 2019
Advanced Nonhematologic Malignancies Trial in Worldwide (MLN2480, MLN0128, Alisertib)
Completed
- Advanced Nonhematologic Malignancies
- MLN2480
- +5 more
-
Boston, Massachusetts
- +13 more
Feb 11, 2020
Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,
Completed
- Advanced Solid Malignancies
- Hematologic Malignancies
- MLN0128
- +2 more
-
Fort Myers, Florida
- +2 more
Jun 28, 2019
Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (MLN0128)
Completed
- Relapsed Multiple Myeloma
- +2 more
- MLN0128
-
San Francisco, California
- +5 more
Jul 31, 2013